This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1A Belot , P Grosclaude , N Bossard , (2008) Cancer incidence and mortality in France over the period 1980–2005. Revue d'Epidémiologie et de Santé Publique 56, 159–175.
4M Gerber (2009) Background review paper on total fat, fatty acid intake and cancers. Ann Nutr Metab 55, 140–161.
5M Gerber (1996) Fiber and breast cancer: another piece of the puzzle – but still an incomplete picture. J Natl Cancer Inst 88, 857–858.
6LA Smit , D Mozaffarian & W Willett (2009) Review of fat and fatty acid requirements and criteria for developing dietary guidelines. Ann Nutr Metab 55, 44–55.
8I Kato , AP Majumdar , J L , (2010) Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. Int J Cancer 127, 942–951.
9Y Kimura , S Kono , K Toyomura , (2007) Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: The Fukuoka Colorectal Cancer Study. Cancer Sci 98, 590–597.
10E Theodoratou , G McNeill , R Cetnarskyj , (2007) Dietary fatty acids and colorectal cancer: a case-control study. Am J Epidemiol 166, 181–195.
11S Kim , DP Sandler , J Galanko , (2010) Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans. Am J Epidemiol 171, 969–979.
12MP Weijenberg , M Luchtenborg , AF de Goeij , (2007) Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes. Cancer Causes Control 18, 865–879.
13MN Hall , H Campos , H Li , (2007) Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16, 314–321.
14MN Hall , JE Chavarro , IM Lee , (2008) A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 17, 1136–1143.
15S Sasazuki , M Inoue , M Iwasaki , (2010) Prospective study group intake of n-3 and n-6 polyunsaturated fatty acids and development of colorectal cancer by subsite: Japan public health center-based prospective study. Int J Cancer .
16CR Daniel , ML McCullough , RC Patel , (2009) Dietary intake of omega-6 and omega-3 fatty acids and risk of colorectal cancer in a prospective cohort of U.S. men and women. Cancer Epidemiol Biomarkers Prev 18, 516–525.
17LM Butler , R Wang , WP Koh , (2009) Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in Singapore Chinese: a prospective study. Int J Cancer 124, 678–686.
18MC Stern , LM Butler , R Corral , (2009) Polyunsaturated fatty acids, DNA repair single nucleotide polymorphisms and colorectal cancer in the Singapore Chinese Health Study. J Nutrigenet Nutrigenomics 2, 273–279.
19AP Hoyer , P Grandjean , T Jørgensen , (1998) Organochlorine exposure and risk of breast cancer. Lancet 352, 9143, 1816–1820.
20GK Pot , A Geelen , EM van Heijningen , (2008) Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: an endoscopy-based case-control study. Int J Cancer 123, 1974–1977.
21M Gerber , J Scali , A Michaud , (2000) Profiles of a healthy diet and its relationship with biomarkers in a population sample from Mediterranean Southern France. J Amer Diet Assoc 100, 1164–1171.
22AP Moreira , CM Sabarense , CM Dias , (2009) Fish oil ingestion reduces the number of aberrant crypt foci and adenoma in 1,2-dimethylhydrazine-induced colon cancer in rats. Braz J Med Biol Res 42, 1167–1172.
23CD Allred , DR Talbert , RC Southard , (2008) PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. J Nutr 138, 250–256.
24A Giros , M Grzybowski , VR Sohn , (2009) Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids docosahexaenoic and eicosapentaenoic. Cancer Prev Res (Phila) 2, 732–742.
25KR Rogers , KD Kikawa , M Mouradian , (2010) Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis 31, 1523–1530.
26C Galli & PC Calder (2009) Effects of fat and fatty acids intake on inflamatory and immune responses. A critical review. Ann Nutr Metab 55, 123–139.
27FA Ukoli , JH Fowke , P Akumabor , (2010) The association of plasma fatty acids with prostate cancer risk in African Americans and Africans Health. J Care Poor Underserved 21, Suppl. 1, 127–147.
28CD Williams , BM Whitley , C Hoyo , (2011) A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutr Res 31, 1–8.
29V Fradet , I Cheng , G Casey & JS Witte (2009) Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 15, 2559–2566.
30J Shannon , J O'Malley , M Mori , (2010) Erythrocyte fatty acids and prostate cancer risk: a comparison of methods. Prostaglandins Leukot Essent Fatty Acids 83, 161–169.
31E Giovannucci , Y Liu , EA Platz , (2007) Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int. J Cancer 121, 1571–1578.
32SY Park , SP Murphy , LR Wilkens , (2007) Fat and meat intake and prostate cancer risk: The multiethnic cohort study. Int. J Cancer 121, 1339–1345.
33P Wallstrom , A Bjartell , B Gullberg , (2007) A prospective study on dietary fat and incidence of prostate cancer (Malmo, Sweden). Cancer Causes Control 18, 1107–1121.
34JE Chavarro , MJ Stampfer , H Li , (2007) A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev 16, 1364–1370.
35M Carayol , P Grosclaude & C Delpierre (2010) Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis. Cancer Causes Control 21, 347–355.
37K Kuriki , K Hirose , K Wakai , (2007) Breast cancer risk and erythrocyte compositions of n-3 highly unsaturated fatty acids. Japanese Int J Cancer 121, 377–385.
39J Shannon , IB King , JW Lampe , (2009) Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China. Am J Clin Nutr 89, 265–276.
40ACM Thiébaut , V Chajès , M Gerber , (2008) Dietary intakes of ω-6 and ω-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer 124, 924–931.
42PM Witt , JH Christensen , EB Schmidt , (2009) Marine n-3 polyunsaturated fatty acids in adipose tissue and breast cancer risk: a case-cohort study from Denmark. Cancer Causes Control 20, 1715–1721.
43TM Brasky , JW Lampe , JD Potter , (2010) Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev 19, 1696–1708.
44HJ Murff , XO Shu , H Li , (2011) Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study. Int J Cancer 128, 1434–1441.
45SC Dijkstra , JW Lampe , RM Ray , (2010) Biomarkers of dietary exposure are associated with lower risk of breast fibroadenomas in Chinese women. J Nutr 140, 1302–1310.
46RE Patterson , SW Flatt , VA Newman , (2011) Marine fatty acid intake is associated with breast cancer prognosis. J Nutr 141, 201–206.
47JD Altenburg & RA Siddiqui (2009) Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells. Mol Cancer Res 7, 1013–1020.
48H Sun , IM Berquin , RT Owens , (2008) Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Res 68, 2912–2919.
49M Saadatian-Elahi , T Norat , J Goudable , (2004) Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer 111, 584–591.
50SD Zuijdgeest-van Leeuwen , MS van der Heijden , (2002) Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. Clin Nutr 21, 225–230.
51CH MacLean , SJ Newberry , WA Mojica , (2006) Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 295, 403–415.
52Z Gong , EA Holly , F Wang , (2010) Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer 127, 1893–1904.
53KS Park , JW Lim & H Kim (2009) Inhibitory mechanism of omega-3 fatty acids in pancreatic inflammation and apoptosis. Ann N Y Acad Sci 1171, 421–427.
54MJ Strouch , Y Ding , MR Salabat , (2011) A high omega-3 fatty acid diet mitigates murine pancreatic precancer development. J Surg Res 165, 75–81.
55K Kuriki , K Wakai , K Matsuo , (2007) Gastric cancer risk and erythrocyte composition of docosahexaenoic acid with anti-inflammatory effects. Cancer Epidemiol Biomarkers Prev 16, 2406–2415.
56MB Veierød , P Laake & DS Thelle (1997) Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev 6, 540–549.
57Y Lu , D Nie , WT Witt , (2008) Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 beta phosphorylation. Mol Cancer Ther 7, 3203–3211.
59M Lindskog , H Gleissman , F Ponthan , (2006) Neuroblastoma cell death in response to docosahexaenoic acid sensitization to chemotherapy and arsenic-induced oxidative stress. Int J Cancer 118, 2584–2593.
60E Germain , V Chajes , S Cognault , (1998) Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int J Cancer; 75, 578–583.
61A Jordan & J Stein (2003) Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2. Eur J Nutr 42, 324–331.
62MC Cha , A Lin & KA Meckling (2005) Low dose docosahexaenoic acid protects normal colonic epithelial cells from araC toxicity. BM Pharmacol 5, 7–14.
63P Bougnoux , N Hajjaji , MN Ferrasson , (2009) Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer 101, 1978–1985.
64A Dewey , C Baughan , TP Dean , (2007) Eicosapentaneoic (EPAan oméga-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane database of systematic reviews .
65KC Fearon , MD Barber , AG Moses , (2006) Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24, 3401–3407.
66BS van der Meij , JA Langius , EF Smit , (2010) Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr 140, 1774–1780.
67RA Murphy , M Mourtzakis , QS Chu , (2010) Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients. J Nutr 140, 1602–1606.
68RA Murphy , M Mourtzakis , QS Chu , (2011) Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 117, 1775–1782.
69RA Murphy , M Mourtzakis , QS Chu , (2011) Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer, .